Records containing: Lupus Nephritis (LN)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-16A Clinical Study on the Safety and Efficacy of CD19-Targeted Universal CAR-γδ T Cells in Relapsed/Refractory Autoimmune Nephropathy
-
CLINICAL_TRIALS study record update · 2026-04-13A Dose Escalation Study Investigating Bispecific Antibody Therapy in Patients With Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2026-03-25A Phase 1, Open Label Dose Escalating Study of HB2198, a Tetravalent Bispecific Anti-CD19/CD20 Antibody With Dual Fc Domains, in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-03-12The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
-
CLINICAL_TRIALS study record update · 2026-03-10Open-Label, Non-Randomized, Single-Arm, Phase 1/2 Study of Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-04An Exploratory Clinical Study on the Safety and Efficacy of YTS109 Cell in Subjects With Relapsing/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-03-02An Exploratory Clinical Study on the Safety and Efficacy of YTS109 Cell in Subjects With Relapsing/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-03-02An Exploratory Clinical Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-23CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2026-02-09Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2026-02-03Multi-center, Phase 1/2 Study of an Autologous Anti-CD20/BCMA CAR T Cell Therapy (C-CAR168) for the Treatment of Autoimmune Disease Refractory to Standard Therapy
-
CLINICAL_TRIALS study record update · 2026-01-23Web-Based Data Collection Through the Research Accelerated by You (RAY) Lupus Registry
-
CLINICAL_TRIALS study record update · 2026-01-23An Open-label, Multi-center, Single-arm Phase 1/2 Study to Assess Tolerability, Safety and Efficacy of CRC01 in Participants With Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-01-23A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of HSK39297 Tablets in Patients With Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2026-01-09Phase I, IIa, Single-Arm, Study of BCMA-CD19-IL-15/IL15sushi cCAR T for the Treatment of Refractory Systemic Lupus Erythematosus, With or Without Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2025-11-20Safety and Efficacy of ONTO1 in Lupus
-
CLINICAL_TRIALS study record update · 2025-11-18A Randomized, Controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of HLX79 (Human Sialidase Fusion Protein) in Combination With Rituximab Injection (HLX01, Anti-CD20 Antibody) Versus Placebo in Patients With Active Glomerulonephritis
-
CLINICAL_TRIALS study record update · 2025-08-19The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis in Upper Egypt ( Single Center Study)
-
CLINICAL_TRIALS study record update · 2025-06-25SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis: Study Design and Protocol
-
CLINICAL_TRIALS study record update · 2025-06-11A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics and Efficacy of Subcutaneous Injection of MSC303 for the Treatment of Immune Glomerular Diseases
-
CLINICAL_TRIALS study record update · 2025-05-23A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter, Multinational Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Active Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2025-05-13An Exploratory Clinical Study of YTS109 Cell in Subjects With Refractory Disease Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-04-20A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Clinical Activity of ADX-097 Administered Subcutaneously in Male and Female Participants Aged 18 Years or Older With IgAN, LN, or C3G
-
CLINICAL_TRIALS study record update · 2025-03-30A Study of Equecabtagene Autoleucel Injection (Eque-cel) in the Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2024-12-16Assessment of Urinary Congophilia as an Indicator of Disease Activity of Lupus Nephritis